创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Key Advantages of Mouse-Derived Immune System Models

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-08 14:48
  • Views:

(Summary description)In the field of biomedical research, immune system models have always been an important tool for researchers. In recent years, with its unique advantages, the murine immune system model of InnoModels Biotechnology has gradually emerged as an important tool for researchers, providing powerful support for the study of many diseases. In this article, we will introduce the main advantages of InnoModels' murine immune system model and discuss its application prospects in biomedical research.

InnoModels Biotechnology: Key Advantages of Mouse-Derived Immune System Models

(Summary description)In the field of biomedical research, immune system models have always been an important tool for researchers. In recent years, with its unique advantages, the murine immune system model of InnoModels Biotechnology has gradually emerged as an important tool for researchers, providing powerful support for the study of many diseases. In this article, we will introduce the main advantages of InnoModels' murine immune system model and discuss its application prospects in biomedical research.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-08 14:48
  • Views:
Information

In the field of biomedical research, immune system models have always been an important tool for researchers. In recent years, with its unique advantages, the murine immune system model of InnoModels Biotechnology has gradually emerged as an important tool for researchers, providing powerful support for the study of many diseases. In this article, we will introduce the main advantages of InnoModels' murine immune system model and discuss its application prospects in biomedical research.
1、Highly simulate the human immune system
The mouse-derived immune system model of InnoModels uses gene editing technology to introduce genes related to the human immune system into the mouse genome, thus realizing the goal of constructing a highly simulated human immune system in the mouse. This model can simulate the complexity and diversity of the human immune system, providing a more realistic experimental environment for the study of disease occurrence, development and treatment.
2. Highly controllable
Compared with the traditional immune system model, InnoModels' murine immune system model is more controllable. Researchers can precisely control gene editing to achieve targeted regulation of specific components of the immune system, signaling pathways or disease models. This highly controllable feature makes the research process more precise and reliable, and is conducive to revealing the essential laws of the immune system.

 


3、Easy to operate and reproduce
As a commonly used experimental animal, rodents are easy to raise, reproduce quickly and operate easily. InnoModels Biotechnology rodent immune system model inherits these advantages, which enables researchers to obtain a large number of experimental animals in a short period of time, accelerating the research process. In addition, the in-depth study of the rodent genome also provides researchers with abundant genetic resources and tools to facilitate various experimental operations.
4. Prospects for wide application
The model of murine immune system has a broad application prospect in the field of biomedical research. First, the model can be used to study the pathogenesis of immune-related diseases, such as autoimmune diseases, infectious diseases and tumors. By simulating the pathological process of human immune system, it helps to discover new therapeutic targets and methods. Second, the model can be used for drug screening and evaluation. Researchers can use the model to evaluate the efficacy and safety of drug candidates, providing strong support for new drug development. Finally, the model can also be used to study the normal physiological functions of the immune system, providing a powerful tool to reveal the mysteries of the immune system.
In conclusion, with its advantages of highly simulating the human immune system, controllability, ease of manipulation and reproduction, as well as the prospect of wide application, the InnoModels Biotechnology murine immune system model has demonstrated great potential and value in the field of biomedical research. With the continuous development and improvement of the technology, it is believed that this model will bring broader application prospects for disease research, drug development and immunotherapy.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司